BioTuesdays

Category - News

Canopy Growth Logo
Developments

Canopy Growth updates U.S. hemp, CBD operations

Following passage of the U.S. 2018 Farm Bill, Canopy Growth (NYSE:CGC;TSX: WEED) provided an update of its hemp operations and expanded pathways to the American market for hemp-based products, including CBD products...

January 8, 2019
Millendo Therapeutics
Markets

Ladenburg starts Millendo Therapeutics at buy; PT $29

Ladenburg Thalmann launched coverage of Millendo Therapeutics (NASDAQ:MLND) with a “buy” rating and $29 price target. The stock closed at $7.65 on Jan. 3. Millendo is a clinical-stage company focusing on the development...

January 4, 2019
Chembio Diagnostics
Markets

Canaccord starts Chembio Diagnostics at buy; PT $9

Canaccord Genuity launched coverage of Chembio Diagnostics (NASDAQ:CEMI) with a “buy” rating and $9 price target. The stock closed at $5.48 on Jan. 3. “In our opinion, Chembio is an underappreciated player in the...

January 4, 2019
Synthorx
Markets

HCW starts Synthorx at buy; PT $30

H.C. Wainwright initiated coverage of Synthorx (NASDAQ:THOR) with a “buy” rating and $30 price target. The stock closed at $17.38 on Dec. 31. Synthorx’s Expanded Genetic Alphabet (EGA) technology generates a modular...

January 2, 2019
ADMA Biologics Logo
Markets

Dawson James starts ADMA Biologics at buy; PT $7

Dawson James initiated coverage of ADMA Biologics (NASDAQ:ADMA) with a “buy” rating and $7 price target. The stock closed at $2.34 on Dec. 27. ADMA is focused on bringing a high-value, potent intravenous immunoglobulin...

December 28, 2018
Corbus Pharmaceuticals
Markets

HCW starts Corbus Pharma at buy; PT $24

H.C. Wainwright initiated coverage of Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) with a “buy” rating and $24 price target. The stock closed at $5.26 on Dec. 24. The company’s lead compound, lenabasum, is a...

December 26, 2018
NeuroMetrix
Markets

HCW starts NeuroMetrix at buy; PT $5

H.C. Wainwright launched coverage of NeuroMatrix (NASDAQ:NURO) with a “buy” rating and price target of $5. The stock closed at 68 cents on Dec. 24. NeuroMetrix is a healthcare technology company that has two products on...

December 26, 2018